Navigation Links
For migrating sparrows, kids have a compass, but adults have the map
Date:11/5/2007

Even bird brains can get to know an entire continent -- but it takes them a year of migration to do so, suggests a Princeton research team.

The scientists have shown that migrating adult sparrows can find their way to their winter nesting grounds even after being thrown off course by thousands of miles, adjusting their flight plan to compensate for the displacement. However, similarly displaced juvenile birds, which have not yet made the complete round trip, are only able to orient themselves southward, indicating that songbirds' innate sense of direction must be augmented with experience if they are to find their way home.

"This is the first experiment to show that when it comes to songbird migration, age makes a difference," said team member Martin Wikelski, an associate professor of ecology and evolutionary biology. "The results indicate that the adult birds possess a navigational map that encompasses at least the continental U.S., and possibly the entire globe."

Two longstanding questions about migrant songbirds are how quickly they recover when thrown off course -- as they can be when they encounter powerful winds -- and just what navigational tools they use to do so. To address the two questions, the team decided to fit a group of white-crowned sparrows with tiny radio transmitters no heavier than a paper clip and track their movements from a small plane.

The team first brought 30 sparrows to Princeton from northern Washington state, where the birds had been in the process of migrating southward from their summer breeding grounds in Alaska. Half the birds were juveniles of about three months in age that had never migrated before, while the other half were adults that had made the round trip to their wintering site in the southwestern United States at least once.

After the birds were released, they attempted to resume their migration, but both age groups grew disoriented quickly.

"All the birds sc
'/>"/>

Contact: Chad Boutin
cboutin@princeton.edu
609-258-5729
Princeton University
Source:Eurekalert

Page: 1 2

Related biology news :

1. Migrating squid drove evolution of sonar in whales and dolphins, researchers argue
2. Meth exposure in young adults leads to long-term behavioral consequences

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...University Medical Center researchers have figured...glioma may be better able to resist radiation ther...ing pathway in these cancer stem cells, they were ... in a laboratory experiment. , The work builds ... cells resist the effects of radiation much better...
(Date:12/2/2009)...e smokeless tobacco product called moist snuff pl...nnesota to urge the tobacco industry to change man...carcinogens. Their study is published online in AC...y . It reports that this category of tobacco produ...oxic and cancer-causing substances. Called polycyc...
(Date:12/2/2009)...r muscles can twitch, before the thought telling i...te of sortscalled an ion channelmust open in the s...chemical signals that spur the cell to action. New...and Technology (NIST) has allowed scientists to ob... the first time, potentially offering insights for...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Nervy research: Researchers take initial look at ion channels in a model system 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 1Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 2Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product 13449 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 1Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 2Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 3Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 4Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 5Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 6Catalyst Pharmaceutical Partners Reports Second Quarter 2009 Financial Results 13447 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 1Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 2Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 3Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 4Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 5Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 6Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 7Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 8Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 9Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 10Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 11Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 12Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 13Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 14Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 15Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 16Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 17Warner Chilcott Reports Operating Results for the Quarter Ended June 30 2009 and Updates 2009 Full Year Guidance 53933 18
...pidly distributing antibiotics to people,exposed t...ld by,itself, prevent about 70 percent of anthrax ...s from the Johns Hopkins Bloomberg School of,Publi...rcent, their,study found that at least 63 percent ...vaccine before an anthrax attack, which might not ...
... Southwestern Medical Center at Dallas,researchers...s of mice,to fight against amyloid proteins that c...ic of Alzheimer,s disease.,For years scientists ha...ed vaccine to slow the progression of the disease ...ave created a gene-based,vaccine aimed at stimulat...
...ientists have believed that neurons need a long pe...s before they take on their adult role. But after ...hese cells develop, a team of researchers at the S...eurons come into this world with a good idea about...is detailed in a paper in the March 24 issue of Ne...
Other Biology News:Study Models Impact Of Anthrax Vaccine 2Scientists identify molecular events that drive cell senescence 2First real-time view of developing neurons reveals surprises, say Stanford researchers 2
(Date:12/2/2009)...-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics...nced today that in connection with its previously ...rcised in full their over-allotment option and pur...omprised of one common share and 0.4 of a common s...US$3.00 per unit. Each whole common share purchase...
(Date:12/2/2009)...e/ -- S*BIO Pte Ltd today announced data presentat...The American Society of Hematology 51st Annual Mee...l be presented on the clinical results from the Ph...s safety, tolerability and pharmacokinetic/pharmac...om 100 to 600 mg. These doses were administered on...
(Date:12/2/2009)...ding scientific magazine covering the life science...igent” EMCCD camera fourth among the publica... (PRWEB) December 2, 2009 ...trics ®, a designer and manufacturer of high-p...nces, was ranked fourth among The Scientist’...
(Date:12/1/2009).../ -- Reportlinker.com announces that a new market ..., Industrial Enzymes - A Global Market Report ,...ial-Enzymes---A-Global-Market-Report.html ,, I...strong players and a host of small suppliers engag...d commoditization characterize the industry. Razor...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
... Celator Pharmaceuticals today,announced that Scot...o,present at the BIO Investor Forum in San Francis...and an update on the company,s clinical,developmen...sday, October,29, 2008 at 1:45 PM PDT in the Marin...pleased to announce that Dr. Arthur Louie, chief,m...
...Alfacell Corporation,(Nasdaq: ACEL ) today announ...scal year ended July 31, 2008, filed with the Secu...ncluded an audit opinion from its independent,regi... about the company,s,ability to continue as a goin...compliance with NASDAQ Marketplace Rule 4350(b)(1)...
...pril 27, 2009 to Regain Compliance with $1.00 ...IN, Calif., Oct. 23 Peregrine,Pharmaceuticals, In...tical,company developing monoclonal antibodies for...ons, today announced that it has received a letter...al time to regain,compliance with the minimum bid ...
Other Biology Technology:Celator(R) Pharmaceuticals To Present at 2008 BIO Investor Forum 2Alfacell Receives Going Concern Audit Opinion 2Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2
Sf21 Cells (SFM Adapted) from Invitrogen
6-carboxy-2',4,4',5',7,7'-hexachlorofluorescein, succinimidyl ester (6-HEX, SE) *single isomer* from Molecular Probes (Invitrogen)
...mmunogen: Synthetic peptide derived from the C-ter...city: Specific for the junctophilin-2 protein. Re... muscle homogenates frozen mouse skeletal muscle t...tochemistry(froz) ImmunofluorescenceStorage: Store...
Goat Anti-Laminin gamma-2 (G-16) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: